Roche Expands Digital Pathology Platform with Over 20 AI Algorithms to Enhance Cancer Research and Precision Medicine

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians...

September 09, 2024 | Monday | News
MSD and EyeBio Announce Initiation of Phase 2b/3 BRUNELLO Trial for Restoret™ (MK-3000) in the Treatment of Diabetic Macular Edema

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co., Inc., Rahway, N.J., US...

September 05, 2024 | Thursday | News
Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm St...

September 04, 2024 | Wednesday | News
Renaissance Lakewood Expands CDMO Operations with New State-of-the-Art Warehouse Facility

Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO),  announc...

September 04, 2024 | Wednesday | News
Avance Clinical Expands Global Site Partnership Network with 2,000 North American Sites, Enhancing Biotech Clinical Development

Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance ...

September 02, 2024 | Monday | News
Novavax Prepares to Launch Protein-Based COVID-19 Vaccine in Thousands of U.S. Locations with Pre-Filled Syringes

Novavax expects pre-filled syringes will be broadly available in thousands of locations across the U.S. Novavax's vaccine is the only protein-based op...

September 02, 2024 | Monday | News
Pensar Medical and Centurion Therapeutics Partner to Expand Access to Advanced Wound Care with Innovative Microdoc® sNPWT System

Pensar Medical, a leading innovator in negative pressure wound therapy (NPWT), today announced a strategic partnership with Centurion Therapeutics for ...

August 30, 2024 | Friday | News
Celltrion USA Expands Patient Access to ZYMFENTRA® Through Agreement with Cigna and Express Scripts

Celltrion USA announced that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the p...

August 29, 2024 | Thursday | News
Biocon Biologics Secures Global Market Access for Bmab 1200 with Janssen Settlement Agreement

  Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has sign...

August 29, 2024 | Thursday | News
Eli Lilly Launches Affordable Zepbound® Single-Dose Vials for Self-Pay Patients, Offering Over 50% Savings on Obesity Treatment

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incr...

August 28, 2024 | Wednesday | News
Sibel Health Expands Capabilities with New FDA Clearances for ANNE® Wearable Sensors

Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. I...

August 23, 2024 | Friday | News
FDA Accepts Application for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Acceptance based on Phase 3 CheckMate -9DW trial results demonstrating improved survival with Opdivo (nivolumab) plus Yervoy(ipilimumab) compared to in...

August 22, 2024 | Thursday | News
Emergent BioSolutions Completes $30 Million Sale of Baltimore-Camden Facility to Bora Pharmaceuticals

Emergent BioSolutions Inc.  announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...

August 21, 2024 | Wednesday | News
GE HealthCare Partners with UC San Diego to Enhance MRI Techniques for Women's Pelvic Health

Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic di...

August 20, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close